- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 250.5M sh |
| Shares Diluted | FY 2024 · Nov 30, 2023 | 230.73M sh |
| Capex | FY 2024 · Nov 30, 2023 | $130.72K |
| Operating Cash Flow | FY 2024 · Nov 30, 2023 | −$1.12M |
| Cash And Equivalents | FY 2024 · Nov 30, 2023 | $5.57K |
| Current Liabilities | FY 2024 · Nov 30, 2023 | $1.51M |
| Total Liabilities | FY 2024 · Nov 30, 2023 | $3.04M |
| Current Assets | FY 2024 · Nov 30, 2023 | $21.01K |
| Total Assets | FY 2024 · Nov 30, 2023 | $811.52K |
| Eps Diluted | FY 2024 · Nov 30, 2023 | −$0.04 |
| Eps Basic | FY 2024 · Nov 30, 2023 | −$0.04 |
| Sga Expense restated | FY 2024 · Nov 30, 2023 | $1.54M |
| Net Income | FY 2024 · Nov 30, 2023 | −$9.09M |
| Operating Income restated | FY 2024 · Nov 30, 2023 | −$8.7M |
| Gross Profit | FY 2024 · Nov 30, 2023 | $229.73K |
| Cost Of Revenue | FY 2024 · Nov 30, 2023 | $96.15K |
| Revenue | FY 2024 · Nov 30, 2023 | $325.88K |
| Stockholders Equity | FY 2024 · Nov 30, 2022 | −$572.46K |